Astellas Pharma Europe B.V Clinical Trials
Sponsors / Astellas Pharma Europe B.V
Astellas Pharma Europe B.V is listed as the lead sponsor on 108 clinical trials registered with ClinicalTrials.gov. Across the portfolio, 1 are in recruitment, 0 are active non-recruiting, and 102 have reached completion. 4 trials have been terminated or withdrawn. The most common reasons cited for termination include safety concerns. Across the portfolio, planned enrollment totals 73,339 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
108
Total Trials
1
Recruiting
0
Other Active
102
Completed
4
Terminated / Withdrawn
73,339
Total Enrollment
Termination reasons: Other75% · Safety25%
Recent Terminations
- NSAID-induced Gastropathy"Internal reassessment of the medicinal product development strategy by Sponsor"
- Healthy Subjects"The study has been terminated because of operational reasons."
- Healthy Subjects"Gastrointestinal safety findings"
- NCT01533844 Stopped Sep 2014Clostridium Difficile"Terminated due to the fact that the required number of trial subjects was not met."
Active Trials (0 total)
- NCT07291258